Vaccine, Medical Health, Astrazeneca, Who

Vaccine, Medical Health

Vaccine makers should license technology to overcome 'grotesque' inequity - WHO

Vaccine makers should license technology to overcome 'grotesque' inequity - WHO

22/3/2021 10:25:00 PM

Vaccine makers should license technology to overcome 'grotesque' inequity - WHO

More producers of COVID-19 vaccines should follow the example of AstraZeneca and license their technology to other manufacturers, the head of the ...

BookmarkGENEVA/ZURICH: More producers of COVID-19 vaccines should follow AstraZeneca's lead and license technology to other manufacturers, the World Health Organization's head said on Monday, as he described continuing vaccine inequity as"grotesque".

Victoria JC student infected with Covid-19; 103 people quarantined, 2,200 others to be swabbed 7 community cases among 20 new COVID-19 infections in Singapore Victoria Junior College student positive for COVID-19; more than 100 students, staff members quarantined

AstraZeneca's shot, which new U.S. data on Monday showed was safe and effective despite some countries suspending inoculations over health concerns, is being produced in various locations including South Korea's SKBioScience and the Serum Institute of India.

AdvertisementAdvertisementWHO Director-General Tedros Adhanom Ghebreyesus called for more manufacturers to adopt this model to boost supplies, including for the COVAX vaccine sharing programme seeking to speed more shots to developing countries."The gap between number of vaccines administered in rich countries and the number administered through COVAX is growing and becoming more grotesque every day," Tedros told a news conference.

"The inequitable distribution of vaccines is not just a moral outrage. It's also economically and epidemiologically self-defeating."Earlier, AstraZeneca released interim data showing its vaccine, developed with Oxford University, was 79per cent effective in preventing symptomatic COVID-19 and posed no increased risk of blood clots.

AdvertisementAdvertisementWHO chief scientist Soumya Swaminathan called it a"very good vaccine for all age groups".Sweden, Norway, Finland and Denmark have extended suspensions of AstraZeneca's shot as investigations continue into rare blood clotting events.

Still, WHO officials said African countries getting the vaccine via COVAX are moving ahead."They did ask a lot of questions but the demand for the vaccine is extremely high," said WHO senior adviser Bruce Aylward.AdvertisementIt remains possible for COVAX to hit a second-quarter goal of delivering 300 million doses, Aylward said, while acknowledging"teething problems", with SKBioSciences and the Serum Institute hard pressed to satisfy COVAX orders.

"We simply cannot get enough vaccine," Aylward said."We're hoping both companies will be able to scale up and keep up with the rate of deliveries we're aiming for."(Reporting by John Miller, Emma Farge and Silke Koltrowitz; writing by Stephanie Nebehay; Editing by Giles Elgood)

Singapore to extend stay-home notice to 21 days for travellers from higher-risk places Malaysia sees more than 4,500 new COVID-19 cases; authorities say not planning nationwide MCO Many governments helping their country’s media; SPH case no different: Shanmugam Read more: CNA »

S'pore-HK air travel bubble starts May 26, 2 daily flights capped at 200 passengers each for first 2 weeks